[PHARMA] YoY Annualized Quarter Result on 30-Sep-2005 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
22-Nov-2005
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2005
Quarter
30-Sep-2005 [#3]
Profit Trend
QoQ- -11.08%
YoY- -30.9%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Revenue 1,303,204 1,188,221 1,054,569 922,962 798,952 621,316 607,266 13.55%
PBT 88,137 72,434 37,136 55,220 79,352 64,236 66,510 4.79%
Tax -30,154 -25,406 -14,190 -17,949 -29,396 -22,554 -25,761 2.65%
NP 57,982 47,028 22,945 37,270 49,956 41,681 40,749 6.04%
-
NP to SH 56,322 45,348 21,298 34,520 49,956 41,681 40,749 5.53%
-
Tax Rate 34.21% 35.07% 38.21% 32.50% 37.05% 35.11% 38.73% -
Total Cost 1,245,221 1,141,193 1,031,624 885,692 748,996 579,634 566,517 14.01%
-
Net Worth 374,390 335,831 323,006 272,364 255,778 211,412 172,567 13.76%
Dividend
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Div 25,672 21,390 16,399 19,185 - 8,015 1,667 57.66%
Div Payout % 45.58% 47.17% 77.00% 55.58% - 19.23% 4.09% -
Equity
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Net Worth 374,390 335,831 323,006 272,364 255,778 211,412 172,567 13.76%
NOSH 106,968 106,952 106,955 102,778 101,098 100,195 50,019 13.49%
Ratio Analysis
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
NP Margin 4.45% 3.96% 2.18% 4.04% 6.25% 6.71% 6.71% -
ROE 15.04% 13.50% 6.59% 12.67% 19.53% 19.72% 23.61% -
Per Share
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
RPS 1,218.30 1,110.98 985.99 898.01 790.27 620.10 1,214.06 0.05%
EPS 52.65 42.40 19.91 33.59 49.41 41.60 81.47 -7.01%
DPS 24.00 20.00 15.33 18.67 0.00 8.00 3.33 38.94%
NAPS 3.50 3.14 3.02 2.65 2.53 2.11 3.45 0.23%
Adjusted Per Share Value based on latest NOSH - 104,012
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
RPS 90.42 82.44 73.17 64.04 55.44 43.11 42.14 13.55%
EPS 3.91 3.15 1.48 2.40 3.47 2.89 2.83 5.53%
DPS 1.78 1.48 1.14 1.33 0.00 0.56 0.12 56.68%
NAPS 0.2598 0.233 0.2241 0.189 0.1775 0.1467 0.1197 13.77%
Price Multiplier on Financial Quarter End Date
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Date 30/09/08 28/09/07 29/09/06 30/09/05 30/09/04 30/09/03 30/09/02 -
Price 3.24 3.27 3.98 4.95 4.77 4.55 7.68 -
P/RPS 0.27 0.29 0.40 0.55 0.60 0.73 0.63 -13.15%
P/EPS 6.15 7.71 19.99 14.74 9.65 10.94 9.43 -6.87%
EY 16.25 12.97 5.00 6.79 10.36 9.14 10.61 7.35%
DY 7.41 6.12 3.85 3.77 0.00 1.76 0.43 60.64%
P/NAPS 0.93 1.04 1.32 1.87 1.89 2.16 2.23 -13.55%
Price Multiplier on Announcement Date
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Date 24/11/08 22/11/07 13/11/06 22/11/05 26/11/04 14/11/03 22/11/02 -
Price 3.35 3.42 3.65 4.82 4.77 5.00 7.36 -
P/RPS 0.27 0.31 0.37 0.54 0.60 0.81 0.61 -12.69%
P/EPS 6.36 8.07 18.33 14.35 9.65 12.02 9.03 -5.66%
EY 15.72 12.40 5.46 6.97 10.36 8.32 11.07 6.01%
DY 7.16 5.85 4.20 3.87 0.00 1.60 0.45 58.52%
P/NAPS 0.96 1.09 1.21 1.82 1.89 2.37 2.13 -12.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment